FDA authorizes booster doses of Pfizer COVID-19 vaccine for children ages 5 to 11

This Tuesday, the U.S. Food and Drug Administration The FDA has modified the emergency use authorization for the Pfizer COVID-19 vaccine booster for children, authorizing the use of a booster dose